Literature DB >> 22806002

Reliability and validity of autism diagnostic interview-revised, Japanese version.

Kenji J Tsuchiya1, Kaori Matsumoto, Atsuko Yagi, Naoko Inada, Miho Kuroda, Eiko Inokuchi, Tomonori Koyama, Yoko Kamio, Masatsugu Tsujii, Saeko Sakai, Ikuko Mohri, Masako Taniike, Ryoichiro Iwanaga, Kei Ogasahara, Taishi Miyachi, Shunji Nakajima, Iori Tani, Masafumi Ohnishi, Masahiko Inoue, Kazuyo Nomura, Taku Hagiwara, Tokio Uchiyama, Hironobu Ichikawa, Shuji Kobayashi, Ken Miyamoto, Kazuhiko Nakamura, Katsuaki Suzuki, Norio Mori, Nori Takei.   

Abstract

To examine the inter-rater reliability of Autism Diagnostic Interview-Revised, Japanese Version (ADI-R-JV), the authors recruited 51 individuals aged 3-19 years, interviewed by two independent raters. Subsequently, to assess the discriminant and diagnostic validity of ADI-R-JV, the authors investigated 317 individuals aged 2-19 years, who were divided into three diagnostic groups as follows: autistic disorder (AD), pervasive developmental disorder not otherwise specified, and other psychiatric diagnosis or no diagnosis, according to the consensus clinical diagnosis. As regards inter-rater reliability, intraclass correlation coefficients of greater than 0.80 were obtained for all three domains of ADI-R-JV. As regards discriminant validity, the mean scores of the three domains was significantly higher in individuals with AD than in those of other diagnostic groups. As regards diagnostic validity, sensitivity and specificity for correctly diagnosing AD were 0.92 and 0.89, respectively, but sensitivity was 0.55 for individuals younger than 5 years. Specificity was consistently high regardless of age and intelligence. ADI-R-JV was shown to be a reliable tool, and has sufficient discriminant validity and satisfactory diagnostic validity for correctly diagnosing AD, although the diagnostic validity appeared to be compromised with respect to the diagnosis of younger individuals.

Entities:  

Mesh:

Year:  2013        PMID: 22806002     DOI: 10.1007/s10803-012-1606-9

Source DB:  PubMed          Journal:  J Autism Dev Disord        ISSN: 0162-3257


  31 in total

1.  Developing criteria for establishing interrater reliability of specific items: applications to assessment of adaptive behavior.

Authors:  D V Cicchetti; S A Sparrow
Journal:  Am J Ment Defic       Date:  1981-09

2.  The autism diagnostic observation schedule-generic: a standard measure of social and communication deficits associated with the spectrum of autism.

Authors:  C Lord; S Risi; L Lambrecht; E H Cook; B L Leventhal; P C DiLavore; A Pickles; M Rutter
Journal:  J Autism Dev Disord       Date:  2000-06

3.  The use of the ADI-R as a diagnostic tool in the differential diagnosis of children with infantile autism and children with a receptive language disorder.

Authors:  K Mildenberger; S Sitter; M Noterdaeme; H Amorosa
Journal:  Eur Child Adolesc Psychiatry       Date:  2001-12       Impact factor: 4.785

4.  A genomewide screen for autism: strong evidence for linkage to chromosomes 2q, 7q, and 16p.

Authors: 
Journal:  Am J Hum Genet       Date:  2001-07-30       Impact factor: 11.025

5.  Stability and interpersonal agreement of the interview-based diagnosis of autism.

Authors:  A Hill; S Bölte; G Petrova; D Beltcheva; S Tacheva; F Poustka
Journal:  Psychopathology       Date:  2001 Jul-Aug       Impact factor: 1.944

6.  Brief report: validity of Finnish registry-based diagnoses of autism with the ADI-R.

Authors:  K M Lampi; A Sourander; M Gissler; S Niemelä; K Rehnström; E Pulkkinen; L Peltonen; L Von Wendt
Journal:  Acta Paediatr       Date:  2010-09       Impact factor: 2.299

7.  Development and current functioning in adolescents with Asperger syndrome: a comparative study.

Authors:  A Gilchrist; J Green; A Cox; D Burton; M Rutter; A Le Couteur
Journal:  J Child Psychol Psychiatry       Date:  2001-02       Impact factor: 8.982

8.  Reevaluating the incidence of pervasive developmental disorders: impact of elevated rates of detection through implementation of an integrated system of screening in Toyota, Japan.

Authors:  Yuichi Kawamura; Osamu Takahashi; Takashi Ishii
Journal:  Psychiatry Clin Neurosci       Date:  2008-04       Impact factor: 5.188

9.  Utility of the Kyoto Scale of Psychological Development in cognitive assessment of children with pervasive developmental disorders.

Authors:  Tomonori Koyama; Hirokazu Osada; Hiromi Tsujii; Hiroshi Kurita
Journal:  Psychiatry Clin Neurosci       Date:  2009-04       Impact factor: 5.188

10.  Improving the reliability of autism diagnoses: examining the utility of adaptive behavior.

Authors:  Stacey S Tomanik; Deborah A Pearson; Katherine A Loveland; David M Lane; J Bryant Shaw
Journal:  J Autism Dev Disord       Date:  2007-05
View more
  19 in total

1.  An ontology for Autism Spectrum Disorder (ASD) to infer ASD phenotypes from Autism Diagnostic Interview-Revised data.

Authors:  Omri Mugzach; Mor Peleg; Steven C Bagley; Stephen J Guter; Edwin H Cook; Russ B Altman
Journal:  J Biomed Inform       Date:  2015-07-04       Impact factor: 6.317

2.  Effectiveness of using the Modified Checklist for Autism in Toddlers in two-stage screening of autism spectrum disorder at the 18-month health check-up in Japan.

Authors:  Yoko Kamio; Naoko Inada; Tomonori Koyama; Eiko Inokuchi; Kenji Tsuchiya; Miho Kuroda
Journal:  J Autism Dev Disord       Date:  2014-01

3.  Clinical Validity of the ADI-R in a US-Based Latino Population.

Authors:  Sandra B Vanegas; Sandra Magaña; Miguel Morales; Ellyn McNamara
Journal:  J Autism Dev Disord       Date:  2016-05

4.  The autism symptom interview, school-age: A brief telephone interview to identify autism spectrum disorders in 5-to-12-year-old children.

Authors:  Somer L Bishop; Marisela Huerta; Katherine Gotham; Karoline Alexandra Havdahl; Andrew Pickles; Amie Duncan; Vanessa Hus Bal; Lisa Croen; Catherine Lord
Journal:  Autism Res       Date:  2016-06-10       Impact factor: 5.216

5.  Brief report: large individual variation in outcomes of autistic children receiving low-intensity behavioral interventions in community settings.

Authors:  Yoko Kamio; Hideyuki Haraguchi; Atsuko Miyake; Mikio Hiraiwa
Journal:  Child Adolesc Psychiatry Ment Health       Date:  2015-03-25       Impact factor: 3.033

6.  Altered metabolites in the plasma of autism spectrum disorder: a capillary electrophoresis time-of-flight mass spectroscopy study.

Authors:  Hitoshi Kuwabara; Hidenori Yamasue; Shinsuke Koike; Hideyuki Inoue; Yuki Kawakubo; Miho Kuroda; Yosuke Takano; Norichika Iwashiro; Tatsunobu Natsubori; Yuta Aoki; Yukiko Kano; Kiyoto Kasai
Journal:  PLoS One       Date:  2013-09-18       Impact factor: 3.240

7.  Quantitative autistic traits ascertained in a national survey of 22 529 Japanese schoolchildren.

Authors:  Y Kamio; N Inada; A Moriwaki; M Kuroda; T Koyama; H Tsujii; Y Kawakubo; H Kuwabara; K J Tsuchiya; Y Uno; J N Constantino
Journal:  Acta Psychiatr Scand       Date:  2012-11-22       Impact factor: 6.392

8.  Serum levels of soluble platelet endothelial cell adhesion molecule-1 and vascular cell adhesion molecule-1 are decreased in subjects with autism spectrum disorder.

Authors:  Yosuke Kameno; Keiko Iwata; Hideo Matsuzaki; Taishi Miyachi; Kenji J Tsuchiya; Kaori Matsumoto; Yasuhide Iwata; Katsuaki Suzuki; Kazuhiko Nakamura; Masato Maekawa; Masatsugu Tsujii; Toshirou Sugiyama; Norio Mori
Journal:  Mol Autism       Date:  2013-06-17       Impact factor: 7.509

9.  Absence of age-related prefrontal NAA change in adults with autism spectrum disorders.

Authors:  Y Aoki; O Abe; N Yahata; H Kuwabara; T Natsubori; N Iwashiro; Y Takano; H Inoue; Y Kawakubo; W Gonoi; H Sasaki; M Murakami; M Katsura; Y Nippashi; H Takao; A Kunimatsu; H Matsuzaki; K J Tsuchiya; N Kato; K Kasai; H Yamasue
Journal:  Transl Psychiatry       Date:  2012-10-23       Impact factor: 6.222

Review 10.  Diagnostic tests for autism spectrum disorder (ASD) in preschool children.

Authors:  Melinda Randall; Kristine J Egberts; Aarti Samtani; Rob Jpm Scholten; Lotty Hooft; Nuala Livingstone; Katy Sterling-Levis; Susan Woolfenden; Katrina Williams
Journal:  Cochrane Database Syst Rev       Date:  2018-07-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.